Glycosylated antigen CA724 elevated to 9.25 μg/L is more serious if caused by malignant tumors of the GI tract and ovaries, and less serious if caused by benign diseases. Glycosylated antigen 724, also known as cancer antigen 724, or CA724, is a non-specific tumor-associated glycoprotein.Elevated CA724 can be seen in about half of patients with ovarian, gastric, colorectal, breast, and pancreatic cancers, as well as benign diseases such as pancreatitis, cirrhosis of the liver, and ovarian cysts. A CA724 value of 9.25 μg/L is a mild elevation, which may be caused by benign diseases, and generally can be improved or cured by active treatment, only a small number of patients with severe pancreatitis and cirrhosis have more serious conditions. However, there is also a certain risk of malignant tumors of the gastrointestinal tract, which are generally more serious and life-threatening if not treated in time. It is recommended that patients consult a specialist, analyze the possible causes of the disease with other tumor markers, imaging results, clinical manifestations, etc., and follow the doctor’s instructions for further examination or treatment.